Kaizhen Wang

679 total citations
43 papers, 499 citations indexed

About

Kaizhen Wang is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Kaizhen Wang has authored 43 papers receiving a total of 499 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 12 papers in Oncology and 9 papers in Cancer Research. Recurrent topics in Kaizhen Wang's work include CAR-T cell therapy research (7 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Membrane Separation Technologies (5 papers). Kaizhen Wang is often cited by papers focused on CAR-T cell therapy research (7 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Membrane Separation Technologies (5 papers). Kaizhen Wang collaborates with scholars based in China, United States and Hong Kong. Kaizhen Wang's co-authors include Zhou Yong, Congjie Gao, Kuojun Zhang, Zhiqiang Peng, Xiangyu Zhang, Junfang Zheng, Kaifeng Gu, Qian Wang, Sheng Jiang and Xin Wang and has published in prestigious journals such as Advanced Functional Materials, Analytical Chemistry and The Science of The Total Environment.

In The Last Decade

Kaizhen Wang

40 papers receiving 493 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kaizhen Wang China 16 218 140 99 96 85 43 499
Utsav Sen India 13 203 0.9× 108 0.8× 71 0.7× 146 1.5× 24 0.3× 35 479
Runmei Li China 14 161 0.7× 67 0.5× 88 0.9× 207 2.2× 68 0.8× 33 653
Xiaojiang Duan China 16 158 0.7× 69 0.5× 163 1.6× 175 1.8× 129 1.5× 51 644
Bi‐Wen Yeh Taiwan 18 311 1.4× 129 0.9× 90 0.9× 117 1.2× 83 1.0× 33 681
Qingying Wang China 16 261 1.2× 165 1.2× 51 0.5× 61 0.6× 54 0.6× 40 533
Runzhi Zhu China 12 314 1.4× 129 0.9× 193 1.9× 162 1.7× 28 0.3× 23 669
Xiaoping Wang China 13 233 1.1× 172 1.2× 90 0.9× 32 0.3× 28 0.3× 33 504
Shusen Wang China 11 207 0.9× 70 0.5× 38 0.4× 64 0.7× 33 0.4× 16 375
Yongming Zeng China 13 165 0.8× 61 0.4× 45 0.5× 43 0.4× 67 0.8× 50 521

Countries citing papers authored by Kaizhen Wang

Since Specialization
Citations

This map shows the geographic impact of Kaizhen Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kaizhen Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kaizhen Wang more than expected).

Fields of papers citing papers by Kaizhen Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kaizhen Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kaizhen Wang. The network helps show where Kaizhen Wang may publish in the future.

Co-authorship network of co-authors of Kaizhen Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Kaizhen Wang. A scholar is included among the top collaborators of Kaizhen Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kaizhen Wang. Kaizhen Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Xiaonan, et al.. (2025). FRA1 drives melanoma metastasis through an actionable transcriptional network. Oncogene. 44(50). 4895–4909.
2.
Cheng, Yao, Kaizhen Wang, Xiang Ni, et al.. (2025). Discovery, Synthesis, and Activity Evaluation of Novel Small-Molecule Inhibitors Targeting VISTA for Cancer Immunotherapy. Journal of Medicinal Chemistry. 68(5). 5222–5237. 1 indexed citations
3.
Wang, Kaizhen, Wanheng Zhang, Dexiang Wang, et al.. (2025). Discovery of dual PARP/NAMPT inhibitors for the treatment of BRCA wild-type triple-negative breast cancer. Bioorganic & Medicinal Chemistry Letters. 120. 130117–130117. 2 indexed citations
4.
Mao, Jie, Yuxing Wu, Kaizhen Wang, et al.. (2025). Discovery of 1,2,4-benzotriazine derivatives as new hematopoietic progenitor kinase 1 (HPK1) inhibitors. Bioorganic Chemistry. 156. 108158–108158. 2 indexed citations
5.
Miao, Yuhang, Kaizhen Wang, Yuqi Cao, et al.. (2025). Constructing natural phenolic acid mesopores to enhance chemotherapy and reduce accompanied intestinal damage. Journal of Controlled Release. 386. 114124–114124. 1 indexed citations
6.
Xu, Xiaonan, Kaizhen Wang, Eric A. Welsh, et al.. (2024). PTEN Lipid Phosphatase Activity Suppresses Melanoma Formation by Opposing an AKT/mTOR/FRA1 Signaling Axis. Cancer Research. 84(3). 388–404. 8 indexed citations
7.
Liu, Ji, Xinwen Ou, Kaizhen Wang, et al.. (2024). Two‐Photon‐Activated Heavy‐Atom Free AIEgen for Highly Efficient Type I Photodynamic Therapy. Advanced Functional Materials. 34(51). 26 indexed citations
8.
Wang, Kaizhen, Xiang Ni, Sheng Jiang, et al.. (2024). Discovery of small molecules for autophagy-lysosome degradation of immune checkpoint proteins. European Journal of Medicinal Chemistry. 280. 116958–116958. 1 indexed citations
9.
Wang, Kaizhen, Xiangyu Zhang, Yingxin Hu, et al.. (2024). Discovery of novel phenyl urea SHP2 inhibitors with anti-colon cancer and potential immunomodulatory effects. European Journal of Medicinal Chemistry. 281. 117036–117036. 2 indexed citations
10.
Xu, Xiaonan, Yumi Kim, Kaizhen Wang, et al.. (2024). PHGDH Induction by MAPK Is Essential for Melanoma Formation and Creates an Actionable Metabolic Vulnerability. Cancer Research. 85(2). 314–328. 4 indexed citations
11.
Wang, Kaizhen, Hongtao Shen, Tianyu Wang, et al.. (2023). Discovery of diaminotriazine carboxamides as potent inhibitors of hematopoetic progenitor kinase 1. Bioorganic Chemistry. 138. 106682–106682. 5 indexed citations
12.
Wang, Kaizhen, Ke Ye, Xinyuan Zhou, et al.. (2023). Design, synthesis, and evaluation of PD-1/PD-L1 small-molecule inhibitors bearing a rigid indane scaffold. European Journal of Medicinal Chemistry. 256. 115468–115468. 15 indexed citations
13.
Yan, Jun, Kaizhen Wang, Lijuan Gui, et al.. (2023). Diagnosing Orthotopic Lung Tumor Using a NTR-Activatable Near-Infrared Fluorescent Probe by Tracheal Inhalation. Analytical Chemistry. 95(38). 14402–14412. 15 indexed citations
14.
Xu, Xiaonan, Kaizhen Wang, Olga Vera, et al.. (2022). Gain of Chromosome 1q Perturbs a Competitive Endogenous RNA Network to Promote Melanoma Metastasis. Cancer Research. 82(17). 3016–3031. 7 indexed citations
15.
Wang, Kaizhen, Shuhao Wang, Kaifeng Gu, et al.. (2022). Ultra-low pressure PES ultrafiltration membrane with high-flux and enhanced anti-oil-fouling properties prepared via in-situ polycondensation of polyamic acid. The Science of The Total Environment. 842. 156661–156661. 17 indexed citations
16.
Zhang, Kuojun, Kaizhen Wang, Xiangyu Zhang, et al.. (2022). Discovery of Small Molecules Simultaneously Targeting NAD(P)H:Quinone Oxidoreductase 1 and Nicotinamide Phosphoribosyltransferase: Treatment of Drug-Resistant Non-small-Cell Lung Cancer. Journal of Medicinal Chemistry. 65(11). 7746–7769. 22 indexed citations
17.
Vera, Olga, Koji Nakamura, Xiaonan Xu, et al.. (2021). A MAPK/miR-29 Axis Suppresses Melanoma by Targeting MAFG and MYBL2. Cancers. 13(6). 1408–1408. 22 indexed citations
18.
Wang, Kaizhen, et al.. (2020). Liposomal N-acylethanolamine-hydrolyzing acid amidase (NAAA) inhibitor F96 as a new therapy for colitis. RSC Advances. 10(56). 34197–34202. 6 indexed citations
19.
Zhou, Zhixiong, Fan Zhang, Qing Lu, et al.. (2016). Sedentary Behavior Predicts Changes in Cardiometabolic Risk in Professional Workers. Journal of Occupational and Environmental Medicine. 58(4). e117–e123. 11 indexed citations
20.
Wang, Kaizhen. (2010). Study of establishing lymphoma diagnostic model by SELDI-TOF-MS. Chinese Clinical Oncology. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Utsav Sen Breakdown of academic impact, for papers by Runmei Li Breakdown of academic impact, for papers by Xiaojiang Duan Breakdown of academic impact, for papers by Bi‐Wen Yeh Breakdown of academic impact, for papers by Qingying Wang Breakdown of academic impact, for papers by Runzhi Zhu Breakdown of academic impact, for papers by Xiaoping Wang Breakdown of academic impact, for papers by Shusen Wang Breakdown of academic impact, for papers by Yongming Zeng
Rankless by CCL
2026